Sharptx

1 known investors

Sharp develops small-molecule oral therapies for hereditary disorders such as Gaucher Disease, Familial Frontotemporal Dementia and Niemann Pick Type-C, using its "Disco" discovery platform that combines laboratory automation with computational molecular-physics modeling. It targets patients, providers and healthcare systems seeking first-choice treatments for genetic diseases.